Farallon Capital Management LLC Avrobio, Inc. Transaction History

Farallon Capital Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.58 - $1.31 $1.29 Million - $2.9 Million	-2,216,300 Reduced 71.13%	899,700 $854,000
Q1 2023 May 15, 2023	BUY	$0.76 - $1.82 $1.81 Million - $4.32 Million	2,376,000 Added 321.08%	3,116,000 $3.12 Million
Q1 2021 May 17, 2021	SELL	$10.54 - $19.3 $579,700 - $1.06 Million	-55,000 Reduced 6.92%	740,000 $9.39 Million
Q4 2020 Feb 16, 2021	SELL	$12.79 - $17.1 $3.26 Million - $4.36 Million	-255,000 Reduced 24.29%	795,000 $11.1 Million
Q3 2020 Nov 16, 2020	SELL	$12.99 - $19.41 $6.82 Million - $10.2 Million	-525,000 Reduced 33.33%	1,050,000 $13.7 Million
Q2 2020 Aug 14, 2020	SELL	$12.19 - $22.96 $1.83 Million - $3.44 Million	-150,000 Reduced 8.7%	1,575,000 $27.5 Million
Q1 2020 May 15, 2020	BUY	$10.08 - $27.21 $1.76 Million - $4.76 Million	175,000 Added 11.29%	1,725,000 $26.8 Million
Q3 2019 Nov 14, 2019	BUY	$14.12 - $23.44 $7.26 Million - $12 Million	513,853 Added 49.59%	1,550,000 $21.9 Million
Q2 2019 Aug 14, 2019	BUY	$13.21 - $27.29 $1.8 Million - $3.72 Million	136,147 Added 15.13%	1,036,147 $16.8 Million
Q1 2019 May 15, 2019	BUY	$12.46 - $22.05 $3.12 Million - $5.51 Million	250,000 Added 38.46%	900,000 $19.8 Million
Q4 2018 Feb 14, 2019	BUY	$15.43 - $32.7 $2.85 Million - $6.05 Million	185,000 Added 39.78%	650,000 $10.8 Million
Q3 2018 Nov 14, 2018	BUY	$26.95 - $52.7 $3.01 Million - $5.88 Million	111,600 Added 31.58%	465,000 $24.1 Million
Q2 2018 Aug 14, 2018	BUY	$28.08 - $31.2 $9.92 Million - $11 Million	353,400 New	353,400 $10.1 Million

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.